Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior

NCT ID: NCT01909947

Last Updated: 2019-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

266 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-09-30

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that machine learning methods using a combination of novel, quantitative measures of cardio-respiratory variability can accurately predict the optimal time to extubate extreme preterm infants. In this multicenter prospective study, cardiorespiratory signals will be recorded from 250 extreme preterm infants who are eligible for extubation. Automated signal analysis algorithms will compute a variety of metrics for each infant describing the cardiorespiratory state. Machine learning methods will then be used to find the optimal combination of these statistical measures and clinical features that provide the best overall predictor of extubation readiness. Finally, investigators will develop an Automated system for Prediction of EXtubation (APEX) that will integrate the software for data acquisition, signal analysis, and outcome prediction into a single application suitable for use by medical personnel in the Neonatal Intensive Care Unit (NICU). The performance of APEX will later be clinically validated in 50 additional infants prospectively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At birth, extreme preterm infants (≤28 weeks) have inconsistent respiratory drive, airway instability, surfactant deficiency and immature lungs that frequently result in respiratory failure. Management of these infants is difficult and most will require endotracheal intubation and mechanical ventilation (ETT-MV) within the first days of life to survive. ETT-MV is an invasive therapy that is associated with adverse clinical outcomes including ventilator-associated pneumonia, impaired neurodevelopment, and increased mortality. Consequently, clinicians try to remove ETT-MV as quickly as possible. However, 25 to 35% of these extubation attempts will fail and infants will require reintubation, an intervention that is also associated with increased morbidity and mortality. Therefore physicians must determine the optimal time for extubation which minimizes the duration of ETT-MV and maximizes the chances of success. A variety of objective measures have been proposed to assist with this decision but none has proven to be useful clinically. Investigators from this group have recently explored the predictive power of indices of autonomic nervous system function based on measurements of heart rate (HRV) and respiratory variability (RV). The use of sophisticated, automated algorithms to analyze those cardiorespiratory signals have shown some promising preliminary results in predicting which infants can be extubated successfully.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prediction of Extubation Readiness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intubated extreme preterm infants

Infants with a birth weight ≤ 1250 grams and requiring endotracheal tube and mechanical ventilation

Cardiorespiratory signal acquisition

Intervention Type OTHER

Cardiorespiratory signals will measure heart rate (using electrocardiography), chest and abdominal movements (using respiratory inductance plethysmography) and oxygen saturation (using pulse oximetry). Data will be acquired during 2 recording periods:

1. A 60-minute period while the infant receives any mode of conventional mechanical ventilation
2. A 5-minute period prior to extubation while the mode of ventilation is switched to endotracheal tube CPAP (Continuous Positive Airway Pressure), so that the respiratory pattern will be controlled by the infant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiorespiratory signal acquisition

Cardiorespiratory signals will measure heart rate (using electrocardiography), chest and abdominal movements (using respiratory inductance plethysmography) and oxygen saturation (using pulse oximetry). Data will be acquired during 2 recording periods:

1. A 60-minute period while the infant receives any mode of conventional mechanical ventilation
2. A 5-minute period prior to extubation while the mode of ventilation is switched to endotracheal tube CPAP (Continuous Positive Airway Pressure), so that the respiratory pattern will be controlled by the infant

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All infants admitted to the NICU with a birth weight ≤ 1250 grams AND
* Need for endotracheal tube mechanical ventilation

Exclusion Criteria

* Infants with major congenital anomalies
* Infants with congenital heart disease and cardiac arrhythmias
* Infants receiving vasopressor or sedative drugs at the time of extubation
* Infants extubated directly from high frequency ventilation
* Infants extubated to room air, oxyhood or low-flow nasal cannula
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

Wayne State University

OTHER

Sponsor Role collaborator

Brown University

OTHER

Sponsor Role collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Guilherme Sant'Anna, MD

Associate Professor of Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guilherme M Sant'Anna, MD

Role: STUDY_CHAIR

McGill University

Guilherme M Sant'Anna, MD

Role: PRINCIPAL_INVESTIGATOR

McGill University

Robert E Kearney, PhD

Role: PRINCIPAL_INVESTIGATOR

McGill University

Wissam Shalish, MD

Role: PRINCIPAL_INVESTIGATOR

McGill University

Karen A Brown, MD

Role: PRINCIPAL_INVESTIGATOR

McGill University

Doina Precup

Role: PRINCIPAL_INVESTIGATOR

McGill University

Sanjay Chawla, MD

Role: PRINCIPAL_INVESTIGATOR

Wayne State University

Martin Keszler, MD

Role: PRINCIPAL_INVESTIGATOR

Brown University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wayne State University

Detroit, Michigan, United States

Site Status

Women and Infants Hospital of Rhode Island

Providence, Rhode Island, United States

Site Status

Royal Victoria Hospital

Montreal, Quebec, Canada

Site Status

Montreal Children's Hospital

Montreal, Quebec, Canada

Site Status

Jewish General Hospital

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

References

Explore related publications, articles, or registry entries linked to this study.

Alarcon-Martinez T, Latremouille S, Kovacs L, Kearney RE, Sant'Anna GM, Shalish W. Clinical usefulness of reintubation criteria in extremely preterm infants: a cohort study. Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):643-648. doi: 10.1136/archdischild-2022-325245. Epub 2023 May 16.

Reference Type DERIVED
PMID: 37193586 (View on PubMed)

Shalish W, Kanbar LJ, Rao S, Robles-Rubio CA, Kovacs L, Chawla S, Keszler M, Precup D, Brown K, Kearney RE, Sant'Anna GM. Prediction of Extubation readiness in extremely preterm infants by the automated analysis of cardiorespiratory behavior: study protocol. BMC Pediatr. 2017 Jul 17;17(1):167. doi: 10.1186/s12887-017-0911-z.

Reference Type DERIVED
PMID: 28716018 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

288299

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

12-387-PED

Identifier Type: OTHER

Identifier Source: secondary_id

APEX 01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.